NCT02498509

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Concomitant Mometasone Furoate and Levocabastine HCl in Perennial Allergic Rhinitis Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 459 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 13 Years
• Healthy volunteers: Not accepted

Summary

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Detailed description

A Randomized, Double-blind, Active-controlled, Multicenter phase 3 Clinical trial to evaluate the Efficacy and Safety of Concomitant Mometasone furoate and Levocabastine HCl in Perennial Allergic Rhinitis patients

Conditions

• Rhinitis, Allergic, Perennial

Interventions

Type	Name	Description
DRUG	CKD-342	treatment for 4 weeks after randomization
DRUG	Mometasone furoate	treatment for 4 weeks after randomization
DRUG	Levocabastine HCL	treatment for 4 weeks after randomization

Timeline

• Start date: 2015-05-01
• Primary completion: 2016-03-01
• Completion: 2016-05-01
• First posted: 2015-07-15
• Last updated: 2016-12-26

Locations

1 site across 1 country: South Korea